Moderna, Inc. (MRNA): A Bull Case Theory

We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc. (MRNA)'s share was trading at $26.67 as of 13^th June. MRNA’s trailing P/E was 7.06 according to Yahoo Finance.

[caption id="attachment_1199135" align="aligncenter" width="768"] A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine.[/caption]

Moderna’s stock has fallen nearly 94% from its pandemic-era highs, reflecting deep skepticism around its long-term revenue prospects. However,...